The development of vaccines and drugs is very important in combating the coronavirus disease 2019 (COVID-19) virus. The effectiveness of these developed vaccines and drugs has decreased as a result of the mutation of the COVID-19 virus. Therefore, it is very important to combat COVID-19 mutations. The majority of studies published in the literature are studies other than COVID-19 mutation prediction. We focused on this gap in this study. This study proposes a robust transformer encoder based model with Adam optimizer algorithm called TfrAdmCov for COVID-19 mutation prediction. Our main motivation is to predict the mutations occurring in the COVID-19 virus using the proposed TfrAdmCov model. The experimental results have shown that the proposed TfrAdmCov model outperforms both baseline models and several state-of-the-art models. The proposed TfrAdmCov model reached accuracy of 99.93%, precision of 100.00%, recall of 97.38%, f1-score of 98.67% and MCC of 98.65% on the COVID-19 testing dataset. Moreover, to evaluate the performance of the proposed TfrAdmCov model, we carried out mutation prediction on the influenza A/H3N2 HA dataset. The results obtained are promising for the development of vaccines and drugs.
No takes yet. Share an insight, caveat, or question.
Burukanlı et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: